Gateway Investment Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Gateway Investment Advisers’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$745K	Sell	2,251 -2,890	-56%	-$983K	0.01%	398
2025 Q4	$2.04M	Hold	5,141	–	–	0.02%	282
2025 Q3	$2.34M	Sell	5,141 -748	-13%	-$305K	0.02%	256
2025 Q2	$1.92M	Sell	5,889 -651	-10%	-$180K	0.02%	256
2025 Q1	$1.77M	Sell	6,540 -843	-11%	-$217K	0.02%	267
2024 Q4	$1.74M	Buy	7,383 +1,222	+20%	+$321K	0.02%	269
2024 Q3	$1.69M	Sell	6,161 -516	-8%	-$134K	0.02%	272
2024 Q2	$1.62M	Sell	6,677 -12,360	-65%	-$1.95M	0.02%	270
2024 Q1	$2.85M	Buy	19,037 +6	+0%	+$1K	0.03%	240
2023 Q4	$3.64M	Buy	19,031 +5,080	+36%	+$865K	0.04%	237
2023 Q3	$2.47M	Buy	13,951 +2,393	+21%	+$457K	0.03%	258
2023 Q2	$2.2M	Buy	11,558 +486	+4%	+$96.4K	0.03%	266
2023 Q1	$2.22M	Sell	11,072 -129	-1%	-$27.1K	0.03%	282
2022 Q4	$2.66M	Buy	11,201 +260	+2%	+$55.5K	0.03%	283
2022 Q3	$2.19M	Sell	10,941 -15,324	-58%	-$2.92M	0.03%	304
2022 Q2	$3.83M	Buy	26,265 +26	+0.1%	+$3.69K	0.04%	257
2022 Q1	$4.29M	Buy	26,239 +21,671	+474%	+$3.3M	0.04%	258
2021 Q4	$775K	Sell	4,568 -6	-0.1%	-$1.11K	0.01%	365
2021 Q3	$864K	Buy	4,574 +330	+8%	+$61.9K	0.01%	362
2021 Q2	$719K	Hold	4,244	–	–	0.01%	387
2021 Q1	$599K	Buy	4,244 +10	+0.2%	+$1.5K	0.01%	399
2020 Q4	$550K	Buy	4,234 +77	+2%	+$10.3K	0.01%	399
2020 Q3	$605K	Sell	4,157 -62	-1%	-$8.81K	0.01%	380
2020 Q2	$625K	Hold	4,219	–	–	0.01%	398
2020 Q1	$459K	Sell	4,219 -1	-0%	-$115	0.01%	415
2019 Q4	$486K	Sell	4,220 -97	-2%	-$9.67K	﹤0.01%	442
2019 Q3	$347K	Sell	4,317 -3	-0.1%	-$237	﹤0.01%	489
2019 Q2	$313K	Hold	4,320	–	–	﹤0.01%	625
2019 Q1	$404K	Sell	4,320 -211	-5%	-$17.6K	﹤0.01%	595
2018 Q4	$330K	Buy	4,531 +667	+17%	+$51.3K	﹤0.01%	616
2018 Q3	$338K	Hold	3,864	–	–	﹤0.01%	620
2018 Q2	$381K	Sell	3,864 -37	-0.9%	-$3.67K	﹤0.01%	616
2018 Q1	$465K	Buy	3,901 +330	+9%	+$42.5K	﹤0.01%	602
2017 Q4	$454K	Buy	+3,571	New	+$449K	﹤0.01%	614